Global Tissue Engineering Market Size & Outlook, 2024-2030
Global tissue engineering market, 2018-2030 (US$M)
Related Markets
Global tissue engineering market highlights
- The global tissue engineering market generated a revenue of USD 19,364.3 million in 2024 and is expected to reach USD 43,130.7 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 14.3% by 2030.
- In terms of segment, orthopedics,musculoskeletal, & spine accounted for a revenue of USD 11,465.2 million in 2024.
- Cardiology & Vascular is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 19,364.3 million |
| Market revenue in 2030 | USD 43,130.7 million |
| Growth rate | 14.3% (CAGR from 2024 to 2030) |
| Largest segment | Orthopedics,musculoskeletal, & spine |
| Fastest growing segment | Cardiology & Vascular |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cord blood & Cell Banking, Cancer, GI, Gynecology, Dental, Skin & Integumentary, Urology, Orthopedics,Musculoskeletal, & Spine, Neurology, Cardiology & Vascular |
Other key industry trends
- In terms of revenue, the North America accounted for 51.3% of the global tissue engineering market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 256.5 million by 2030.
Orthopedics,musculoskeletal, & spine was the largest segment with a revenue share of 59.21% in 2024. Horizon Databook has segmented the Global tissue engineering market based on cord blood & cell banking, cancer, gi, gynecology, dental, skin & integumentary, urology, orthopedics,musculoskeletal, & spine, neurology, cardiology & vascular covering the revenue growth of each sub-segment from 2018 to 2030.
Stem cell therapies have significant potential as therapeutics across various clinical applications. This has resulted in substantial global investments in research and clinical translation. Rapid advances in stem cell research aid in improved disease management. Thus, with an increase in the incidence of cancer, diabetes, and other chronic disorders, research on stem cells has increased.
In May 2023, European Pharmaceutical Review (EPR) released an article where it examines how technological advancements are revolutionizing ATMP manufacturing as well as current advances in stem cell therapy for a number of difficult-to-treat diseases or disorders.
According to the researchers, using stem cells from cord blood rather than suitable adult donors has been done in the past and it boosts the possibility of curing HIV with stem cell transplantation in persons of all racial origins.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tissue Engineering Market Scope
Tissue Engineering Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global tissue engineering market size, by regions, 2018-2030 (US$M)
Top 10 countries: Tissue engineering market size, 2024 (US$M)
Global tissue engineering market share, by application, 2024 & 2030 (%, US$M)
Tissue engineering market: Opportunity assessment by country
Global tissue engineering market, by region, 2024 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
